Sasoter, Jian Jay Jofel C.
HRN: 15-53-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
MUPIROCIN 2%, 15G (TUBE)
05/18/2024
05/25/2024
TOPICAL
As Needed
BID
Atopic Dermatitis With Secondary Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes